Molecular Testing in Ovarian Tumours: Challenges from the Pathologist’s Perspective

The use of molecular testing to direct diagnosis and treatment options in ovarian tumours has rapidly expanded in recent years, in particular with regard to the recommendation for routine homologous recombination deficiency (HRD) testing in all patients with high-grade ovarian epithelial tumours. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Dinneen, Kate, Arora, Rupali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10297009/
https://www.ncbi.nlm.nih.gov/pubmed/37370967
http://dx.doi.org/10.3390/diagnostics13122072

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10297009/
https://www.ncbi.nlm.nih.gov/pubmed/37370967
http://dx.doi.org/10.3390/diagnostics13122072

Ejemplares similares